Trial intelligence / Profile preview

New CMC-HA Eye Drop vs Refresh Contacts for Contact Lens Lubrication

NCT01844388Phase 3Completed

Sponsor
Allergan
Start
May 2013
Primary completion
Dec 2013
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 3 trial of carboxymethylcellulose sodium ophthalmic gel, hyaluronic acid sodium salt in dry eye syndrome (DED), sponsored by Allergan. Started May 2013; status: completed.

02

Drugs

carboxymethylcellulose sodium ophthalmic gelhyaluronic acid sodium salt
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01844388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01844388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call